Publications by authors named "Olga M Garcia Morales"
This study aimed to provide a comprehensive analysis of 56 patients admitted to the Lung Cancer Clinical Care Center (C3) at Fundación Santa Fe de Bogotá (FSFB) between 2 May 2022 and 22 April 2024. The focus was on demographic characteristics, smoking history, comorbidities, lung cancer types, TNM classification, treatment modalities, and outcomes. This observational case series study reviewed medical records and included patients over 18 years with a confirmed diagnosis of non-small cell lung cancer (NSCLC).
View Article and Find Full Text PDFArticle Synopsis
- COPD is a significant health issue, and the 2019 GOLD strategy introduced blood eosinophils as a key biomarker to help identify COPD patients at risk for exacerbations and inform treatment decisions.
- A study analyzing a Colombian cohort of COPD patients found that most participants were elderly, with a balanced gender ratio and a notable prevalence of biomass exposure as a risk factor.
- The results revealed varying eosinophil counts among patients, with those who had a history of smoking and frequent exacerbations showing higher counts, alongside a high rate of recorded exacerbations within the study period.
Background: The long-acting bronchodilator tiotropium and single-inhaler combination therapy of inhaled corticosteroids and long-acting beta2-agonists (ICS/LABA) are commonly used for maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Combining these treatments, which have different mechanisms of action, may be more effective than administering the individual components.
Objectives: To assess relative effects of the following treatments on markers of exacerbations, symptoms, quality of life and lung function in patients with COPD.